Results 271 to 280 of about 616,613 (359)

Mitochondrial metabolic remodeling predicts therapeutic response to PegIFN-α in chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Zhang Y, Han X, Xu C, Song Y, Zhu J, Zhou R, Chen Y, Liu M, Xu J, Wu X, Han Q, Chen Z.   +11 more
europepmc   +1 more source

Comparison of efficacy between entecavir and adefovir dipivoxil in lamivudine-refractory patients with chronic hepatitis B

, 2011
Guan Qun
openalex   +1 more source

Data Sheet 1_Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B.pdf

Sukjin Hong (20991200), Jun Hyun Hwang (3190296), Keumoung Kim (20991203), Younghae Do (20991206), Naeun Kwak (20991209), Hyo Rim Suh (20991212), Sujin Choi (3190689), Ben Kang (2266984), Byung-Ho Choe (9364418)   +8 more
openalex   +1 more source

Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status

International Journal of Cancer, EarlyView.
What's New? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt, Sami Kilpinen, Johanna Arola, Benjamin Z. Sundqvist, Tom Böhling, Leif C. Andersson, Harri Sihto   +6 more
wiley   +1 more source

Rhino-Orbital-Cerebral Mucormycosis in a Patient With Chronic Hepatitis B and D Coinfection: A Rare Case Report. [PDF]

Clin Case Rep
Bibi F, Hamza M, Matos OL, Mohsin M, Fareed A, Ambreen F, Abdi KE, Sadat SH.   +7 more
europepmc   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

International Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott, Emma J. West, Rebecca J. Brownlie, Fay Ismail, Christy Ralph, Thomas Heineman, Matt Coffey, Alan A. Melcher, Alison Taylor, Salvatore Papa, Adel Samson   +10 more
wiley   +1 more source

A Case Report of Direct-Acting Antiviral Therapy for Chronic Hepatitis C in a Patient With Dementia Treated in Collaboration With Multiple Specialists. [PDF]

Case Reports Hepatol
Tanie T, Kanda K, Fujikawa H.
europepmc   +1 more source

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma

International Journal of Cancer, EarlyView.
What's New? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, Lukas Flatz, Andrea Forschner   +4 more
wiley   +1 more source

Chronic Hepatitis C in the Direct-Acting Antivirals Era: Carcinogenesis and Clinical Implications. [PDF]

Diseases
Aydin Y, Kurt R, Tahan V, Daglilar E.
europepmc   +1 more source